Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Mar 23;4(5):711–718. doi: 10.1158/1940-6207.CAPR-10-0288

Table 1.

Demographic characteristics of all study subjects included in the analyses, the subjects by intervention group and the subjects by both intervention and diagnosis groups.

Characteristic
Total (N=105)
Placebo (N=51)
Lycopene (N=54)
BPH (N=58)
Prostate cancer (N=47)
BPH (N=58)
Prostate cancer (N=47)
Placebo (N=30)
Lycopene (N=28)
Placebo (N=21)
Lycopene (N=26)
Age (years)
66.9 ± 7.51
69.4 ± 7.1
64.6 ± 7.2
67.6 ± 6.8
66.0 ± 8.3
69.5 ± 6.7
65.6 ± 6.4
69.2 ± 7.8
63.4 ± 8.0
Height (cm)
175.7 ± 7.2
175.5 ± 7.1
175.8 ± 7.4
175.8 ± 7.1
175.4 ± 7.4
175.1 ± 7.4
176.5 ± 6.9
176.1 ± 6.7
174.9 ±8.0
Weight (kg)
86.5 ± 16.4
83.7 ± 14.8
88.9 ± 17.4
86.7 ± 13.4
86.3 ± 19.8
83.1 ± 11.7
89.8 ± 14.2
84.6 ± 18.4
87.7 ±21.3
Body mass index (kg/m2)
28.5 ± 5.3
27.8 ± 4.8
29.3 ± 5.6
28.5 ± 3.9
28.6 ± 6.7
27.9 ± 3.7
29.1 ± 4.0
27.6 ± 6.1
29.5 ± 7.2
Ethnicity (%)
        African-American
100
100
100
100
100
100
100
100
100
Smoking status (%)
        yes 30.5 25.5 35.2 27.6 34.0 26.7 28.6 23.8 42.3
        former/no
69.5
74.5
64.8
72.4
66.0
73.3
71.4
76.2
57.7
Alcohol consumption (%)
        yes 43.8 49.0 38.9 41.4 46.8 50.0 32.1 47.6 46.2
        former/no 56.2 51.0 61.1 58.6 53.2 50.0 67.9 52.4 53.8
1

Mean ± SD